1. Systematic Review of the Quality of Patient Information on the Internet Regarding Inflammatory Bowel Disease Treatments 
Morgan Langille, André Bernard, Chris Rodgers, Stephanie Hughes, Des Leddin, Sander Veldhuyzen van Zanten 
Clinical Gastroenterology and Hepatology 
Volume 8, Issue 4, Pages (April 2010)
DOI: /j.cgh
Copyright © 2010 AGA Institute Terms and Conditions

2. Figure 1
Comparison of the DQS with the GQS for CD and UC websites. Range of DQS is 0–76, and GQS is 1–5.
Clinical Gastroenterology and Hepatology 2010 8, DOI: ( /j.cgh )
Copyright © 2010 AGA Institute Terms and Conditions

3. Figure 2
DQS for each CD or UC website depicting the proportion of points derived from each treatment option within each website.
Clinical Gastroenterology and Hepatology 2010 8, DOI: ( /j.cgh )
Copyright © 2010 AGA Institute Terms and Conditions

4. Figure 3
Number of websites (N = 43) containing information on CD or UC achieving at least 70% of the points on the DQS for an individual treatment option. 5-ASA, mesalamine; AZA, azathioprine.
Clinical Gastroenterology and Hepatology 2010 8, DOI: ( /j.cgh )
Copyright © 2010 AGA Institute Terms and Conditions

5. Figure 4
Correlation of the GQS with the average DISCERN score for websites containing information on the treatment options of CD and UC.
Clinical Gastroenterology and Hepatology 2010 8, DOI: ( /j.cgh )
Copyright © 2010 AGA Institute Terms and Conditions